Literature DB >> 7085876

Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.

E Seeman, H W Wahner, K P Offord, R Kumar, W J Johnson, B L Riggs.   

Abstract

In 100 patients with various types of endocrine dysfunction, we measured bone mineral density (BMD) at the midradius (greater than 95% cortical bone) and distal radius (75% cortical and 25% trabecular bone) by single photon absorptiometry and at the lumbar spine (greater than 66% trabecular bone) using the new technique of dual photon absorptiometry. BMD in each endocrine disorder deviated in at least one site from the sex-specific age regression of 187 normal subjects. For patients with primary hyperparathyroidism, hypercortisolism, and hyperthyroidism this deviation was negative (suggesting bone loss), whereas for patients with secondary hyperparathyroidism due to chronic renal failure, acromegaly, and postsurgical hypoparathyroidism it was positive (suggesting bone gain). When all six states of endocrine dysfunction were compared concomitantly by multivariate analysis of variance, the profile of the changes in BMD differed significantly (P less than 0.001), indicating a nonuniform response of bone to the various hormonal alterations. When values for BMD at each of the three scanning sites were compared the midradius and distal radius did not differ significantly; either of the radius measurements, however, differed significantly (P less than 0.001) from the lumbar spine. Thus, the BMD of the axial skeleton cannot be reliably predicted from measurements made in the appendicular skeleton. We conclude that the effects of endocrine dysfunction on bone density are complex and are both disease and site specific.

Entities:  

Mesh:

Year:  1982        PMID: 7085876      PMCID: PMC370203          DOI: 10.1172/jci110570

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  [Detection of thyreogenic osteopathy with the aid of the modern photon absorption technic].

Authors:  A Bekier
Journal:  Schweiz Med Wochenschr       Date:  1975-03-08

2.  Bone mineral content in patients with primary hyperparathyroidism without radiological evidence of skeletal changes.

Authors:  N Dalén; B Hjern
Journal:  Acta Endocrinol (Copenh)       Date:  1974-02

3.  Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.

Authors:  T J Hahn; V C Boisseau; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

4.  Osteoporosis and fractures following thyrotoxicosis.

Authors:  S A Fraser; J B Anderson; D A Smith; G M Wilson
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

5.  Parathyroid activity and postmenopausal osteoporosis.

Authors:  M Hossain; D A Smith; B E Nordin
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

6.  Radiological signs of bone loss in hyperthyroidism.

Authors:  D A Koutras; P G Pandos; A S Koukoulommati; J Constantes
Journal:  Br J Radiol       Date:  1973-09       Impact factor: 3.039

7.  The nature of the metabolic bone disorder in acromegaly.

Authors:  B L Riggs; R V Randall; H W Wahner; J Jowsey; P J Kelly; M Singh
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

8.  Some quantitative radiological observations in primary and secondary hyperparathyroidism.

Authors:  F H Doyle
Journal:  Br J Radiol       Date:  1966-03       Impact factor: 3.039

9.  Radiology of the skeleton in endocrine diseases.

Authors:  F H Doyle
Journal:  Proc R Soc Med       Date:  1967-11-01

10.  Bone changes in adult patients with abnormal thyroid function (with special reference to 45Ca kinetics and quantitative histology).

Authors:  P Bordier; L Miravet; H Matrajt; D Hioco; A Ryckewaert
Journal:  Proc R Soc Med       Date:  1967-11-01
View more
  67 in total

1.  The differing tempo of growth in bone size, mass, and density in girls is region-specific.

Authors:  S Bass; P D Delmas; G Pearce; E Hendrich; A Tabensky; E Seeman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 2.  Bone mineral density in acromegaly: does growth hormone excess protect against osteoporosis?

Authors:  I Chiodini; V Trischitta; V Carnevale; A Liuzzi; A Scillitani
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

3.  Effects of prematurity, intrauterine growth status, and early dexamethasone treatment on postnatal bone mineralisation.

Authors:  S Kurl; K Heinonen; E Länsimies
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

Review 4.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

5.  Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients.

Authors:  I R Reid; M C Evans; D J Wattie; R Ames; T F Cundy
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

6.  Comparison between radial bone mineral density measured by single photon absorptiometry and histomorphometric bone mass parameters measured on iliac crest biopsies.

Authors:  F Duboeuf; D Uebelhart; G Boivin; C Edouard; P D Delmas; P J Meunier
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

7.  Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.

Authors:  K Amrein; H P Dimai; H Dobnig; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

8.  Total body and regional bone mineral by dual-photon absorptiometry in metabolic bone disease.

Authors:  R B Mazess; W W Peppler; R W Chesney; T A Lange; U Lindgren; E Smith
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

9.  Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy.

Authors:  Yuuki Takamura; Akira Miyauchi; Tomonori Yabuta; Minoru Kihara; Yasuhiro Ito; Akihiro Miya
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

10.  A longitudinal assessment of bone loss in women with levothyroxine-suppressed benign thyroid disease and thyroid cancer.

Authors:  M T McDermott; J J Perloff; G S Kidd
Journal:  Calcif Tissue Int       Date:  1995-06       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.